How I Manage Thrombotic/Thromboembolic Complications in Myeloproliferative Neoplasms.

Abstract:

:Patients with myeloproliferative neoplasms (MPNs), such as polycythemia vera, essential thrombocythemia, and primary myelofibrosis, are at increased risk for arterial and venous thrombosis/thromboembolism. In particular, the risk of splanchnic venous thrombosis, such as portal vein thrombosis or Budd-Chiari syndrome, is significantly higher in patients with MPN than in the normal population. At the same time, MPN patients are at increased risk for severe bleeding. Therefore, the treatment of patients with MPN must be based on their suspected probability of thrombosis/thromboembolism and bleeding. For this purpose, patient and MPN-specific risk factors are used. Patients at expected high risk of thrombosis should receive adequate primary or secondary thromboprophylaxis in addition to cytoreductive therapy. This may consist of antiplatelet agents and/or anticoagulant agents and must be balanced with the individual bleeding risk. The goal is to increase the quality of life and life span of patients with MPNs by preventing (re-)thrombosis and severe bleeding. :Patienten mit Myeloproliferativen Neoplasien (MPN), wie der Polycythämia vera (PV), Essentiellen Thrombozythämie (ET) und Primären Myelofibrose (PMF), sind einem erhöhten Risiko für arterielle und venöse Thromboembolien ausgesetzt. Besonders das Risiko für splanchnische Venenthrombosen, wie die Pfortaderthrombose oder das Budd-Chiari-Syndrom, ist bei Patienten mit MPN vielfach höher als in der Normalbevölkerung. Gleichzeitig besteht bei MPN-Patienten ein erhöhtes Risiko für schwergradige Blutungen. Daher muß sich die Therapie der Patienten mit MPN an der Wahrscheinlichkeit für Thromboembolien und Blutungen orientieren. Hierfür werden patienten- und MPN-spezifische Risikofaktoren herangezogen. Patienten mit zu erwartendem hohem Risiko für Thrombosen sollten zusätzlich zu einer zytoreduktiven Therapie eine angemessene Primär- oder Sekundärprophylaxe erhalten. Diese kann aus Thrombozytenfunktionshemmern und/oder Antikoagulanzien bestehen und muß mit dem individuellen Blutungsrisiko balanciert werden. Ziel ist es, durch die Verhinderung von (Re-)Thrombosen und schwergradigen Blutungen die Lebensqualität und Lebensspanne der Patienten mit MPN zu erhöhen.

journal_name

Hamostaseologie

journal_title

Hamostaseologie

authors

Koschmieder S

doi

10.1055/s-0040-1701474

subject

Has Abstract

pub_date

2020-02-01 00:00:00

pages

47-53

issue

1

eissn

0720-9355

issn

2567-5761

journal_volume

40

pub_type

杂志文章,评审
  • The vulnerable blood.

    abstract::Patients with diabetes are at increased risk of cardiovascular morbidity and mortality. While arteriosclerotic lesions have long been recognized as the underlying cause more recent studies suggest that alterations of the blood are also critically involved. Following plaque rupture, adherence of platelets is followed b...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.5482/HAMO-14-09-0039

    authors: Hess K

    更新日期:2015-01-01 00:00:00

  • [Bleedings under NOAC (non Vitamin-K dependent oral anticoagulants). Evidence and practical management].

    abstract:UNLABELLED:The doses of these drugs are barely tested and the potential clinical thromboembolic risk must be taken into account. Despite the widespread use of NOAC (non vitamin-K dependent oral anticoagulants) and recommendations of regulatory agencies and first consensus meeting on handling the bleeding situation unde...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Koscielny J,Rutkauskaite E

    更新日期:2015-01-01 00:00:00

  • [Recurrent miscarriage or failed in-vitro fertilization: antibodies against annexin V, cardiolipin, beta-2-glycoprotein-1 and APC-resistance].

    abstract:UNLABELLED:Antibodies against annexin-V, a potent anticoagulant abundant in placental tissues, were recently controversially reported to be associated with recurrent miscarriages or failures of in-vitro-fertilization (IVF) attempts. PATIENTS, MATERIAL, METHODS:We screened 56 women (34.7 +/- 4.3 years of age: mean +/- ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Halbmayer WM,Feichtinger W,Kindermann C,Prendinger B,Böhm M

    更新日期:2005-11-01 00:00:00

  • Vitamin K antagonists. Ready to be replaced?

    abstract::For the last decades, anticoagulation for stroke prevention in atrial fibrillation (AF) as well as for the prophylaxis and long-term treatment of venous thromboembolism has been entirely based on vitamin K antagonists (VKA). Although very effective under optimal conditions, long-term treatment with these drugs is flaw...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/ha-12050008

    authors: Steffel J,Luscher TF

    更新日期:2012-01-01 00:00:00

  • [Upper ankle joint prostheses in haemophilia patients].

    abstract:UNLABELLED:Secondary arthrosis of the upper ankle joint (talocalcanean joint) is one of the most frequent forms of haemophilic arthropathy. It is a secondary form of arthrosis not only because of chronic synovitis and cartilage injury resulting from chronic recurrent intraarticular bleeds, but also due to the misalignm...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Berdel P,Schott D,Pagenstert G,Pennekamp P,Oldenburg J,Wirtz DC,Seuser A,Gravius S

    更新日期:2009-10-01 00:00:00

  • Coagulation parameters as predictors of DIC in patients with intact aortic aneurysm.

    abstract::Clinically overt, preoperative, disseminated intravascular coagulation (DIC) is not common in patient with aortic aneurysm. However, cases with large and expanding aneurysm are especially prone for this coagulopathy. Contrary to the clinically overt form compensated DIC in patients with aortic aneurysm seems frequent ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1267/hamo04030162

    authors: Jeleńska MM

    更新日期:2004-08-01 00:00:00

  • Potential Drug Interactions between Recombinant Interleukin-2 and Direct Oral Anticoagulants: Indirect Evidence from In Vivo Animal Studies.

    abstract::Recombinant interleukin-2 (rIL-2) is indicated for metastatic renal cell carcinoma and melanoma. Over recent years low-dose rIL-2 has been studied for the treatment of autoimmune diseases and acute coronary syndrome because of its ability to expand and activate T regulatory (Treg) cells. However, several medical condi...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.1055/a-1120-4064

    authors: Mahmoudpour SH,Valerio L,Douxfils J,Mahan CE,Jankowski M,Quitzau K,Konstantinides SV,Barco S

    更新日期:2020-12-01 00:00:00

  • Complement activation in thrombotic microangiopathy.

    abstract::The endothelium lining the vascular lumen is continuously exposed to complement from the circulation. When erroneously activated on host cells, complement may generate a deleterious effect on the vascular wall leading to endothelial injury, exposure of the subendothelial matrix and platelet activation. In this review ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-12-12-0025

    authors: Karpman D,Tati R

    更新日期:2013-05-29 00:00:00

  • Cofactor-Independent Antiphospholipid Antibodies: Implications for Pathogenesis, Diagnosis, and Treatment of Antiphospholipid Syndrome.

    abstract::The antiphospholipid syndrome (APS) has occupied haemostaseologists, rheumatologists and obstetricians since its initial description 35 years ago. Its name has been coined because of the antibodies against phospholipids which were the common property of affected patients. In particular, the pathogenesis of APS has bee...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1055/s-0038-1675355

    authors: Lackner KJ,Müller-Calleja N

    更新日期:2019-06-01 00:00:00

  • Nucleic acid aptamers and their complimentary antidotes. Entering an era of antithrombotic pharmacobiologic therapy.

    abstract::The translation of fundamental science-based constructs to the preemptive identification and optimal management of individuals with or those at risk for thrombotic disorders of the cardiovascular system has taken a step closer to being realized with the development of molecular technologies that include nucleic acid a...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Becker RC,Oney S,Becker KC,Rusconi CP,Sullenger B

    更新日期:2007-12-01 00:00:00

  • Understanding and Preventing Placenta-Mediated Pregnancy Complications.

    abstract::Placenta-mediated pregnancy complications are clinically important conditions and include preeclampsia, placental abruption, intrauterine growth restriction, and late fetal loss. Pathophysiology is complex, and may be linked to prothrombotic disorders such as antiphospholipid syndrome, whose understanding is still evo...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.1055/a-1184-8388

    authors: Skeith L,Blondon M,Ní Áinle F

    更新日期:2020-08-01 00:00:00

  • [Factor XIII in man: a review].

    abstract::Activated by calcium and thrombin, factor XIII (FXIIIa) cross-links fibrin, thus increasing the stability of the fibrin clot. Furthermore, the hemostatic and reparative function of factor XIIIa is mediated by cross-linking other proteins like alpha(2)-plasmin-inhibitor, fibronectin, and collagen. The FXIII Val34Leu po...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Dufner GS,Marbet GA

    更新日期:2002-02-01 00:00:00

  • Management of acquired haemophilia A.

    abstract::Acquired haemophilia A (AHA) is caused by autoantibody inhibitors of coagulation factor VIII (FVIII : C). Recent onset of bleeds and isolated prolongation of the activated partial thromboplastin time (aPTT) are characteristic features of the disorder. Reduced FVIII : C activity and a detectable FVIII : C inhibitor in ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-14-11-0064

    authors: Tiede A,Scharf RE,Dobbelstein C,Werwitzke S

    更新日期:2015-01-01 00:00:00

  • [Does FVIII-activity increase with age in patients with haemophilia A and carriers of haemophilia A?].

    abstract:UNLABELLED:The retrospective cohort study surveys the influence of age, co-morbidity and laboratory values on FVIII-activity (FVIII:C) in patients with haemophilia A with (mild n = 48, moderate n = 10, severe n = 7 and carriers n = 23). Median observation was 19 years for patients with haemophilia A and 9,5 years for c...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Delbrück C,Haferland I,Scholz K,Asmelash G,Makki V,Müller S,Krekeler S,Alesci S,Miesbach W

    更新日期:2011-11-01 00:00:00

  • Health Care Transition of Adolescents and Young Adults with Haemophilia: the Situation in Germany and the Munich experience.

    abstract::Patients suffering from haemophilia encounter various phases in life, in which individual needs, life situations, and self- and disease perception change rapidly. One of these phases spans from the beginning of puberty until early adulthood, in which individuals gain self-responsibility and reach independence and auto...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1055/s-0039-3402804

    authors: Bidlingmaier C,Olivieri M,Schilling FH,Kurnik K,Pekrul I

    更新日期:2020-02-01 00:00:00

  • Methylation analysis of the promoter region and intron 1 of the factor VIII gene in haemophilia A patients.

    abstract::Methylation, CpG island, promoter, intron 1 Haemophilia A is the most common X-linked inherited coagulation disorder caused by a deficiency of the factor VIII protein (FVIII). A plethora of different mutations in the factor VIII gene (F8) have been identified as causative for this bleeding disease including a few prom...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Zimmermann MA,Hansmann T,Haaf T,Oldenburg J,Müller CR,Rost S

    更新日期:2013-01-01 00:00:00

  • [Hemostasis disorders in obstetrics and gynecology].

    abstract::A survey is given on the clinical important haemostatic facts and diseases in gynaecology and obstetrics from the viewpoint of the gynecologist and obstetrician. ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1267/hämo04040252

    authors: Heilmann L

    更新日期:2004-11-01 00:00:00

  • Screening for haemorrhagic disorders in paediatric patients by means of a questionnaire.

    abstract:AIM:In children, screening for haemorrhagic disorders is further complicated by the fact that infants and young children with mild disease in many cases most likely will not have a significant history of easy bruising or bleeding making the efficacy of a questionnaire even more questionable. PATIENTS, METHODS:We compa...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Music I,Novak M,Acham-Roschitz B,Muntean W

    更新日期:2009-10-01 00:00:00

  • [Congenital and acquired thrombocytopenias].

    abstract::An overview is given on congenital and acquired thrombocytopenias, their pathophysiology, symptoms, diagnosis and therapy with emphasizing heparin-induced thrombocytopenia (HIT) and the thrombotic thrombocytopenic purpura (TTP). ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Scharf RE

    更新日期:2003-11-01 00:00:00

  • Clot waveform analysis in patients with haemophilia A.

    abstract:UNLABELLED:Clot waveform analysis extends the interpretation of aPTT measurement curves. The curve is mathematically processed to obtain information about fibrin formation kinetics including semiquantitative determination of thrombin, prothrombinase and tenase activity. PATIENTS, METHOD:In this study the feasibility o...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.5482/HAMO-14-02-0016

    authors: Siegemund T,Scholz U,Schobess R,Siegemund A

    更新日期:2014-01-01 00:00:00

  • Analysis of an Inherited Dysfibrinogenemia Pedigree Associated with a Heterozygous Mutation in the FGA Gene.

    abstract:OBJECTIVE: This article aims to analyze the phenotype and genotype of an inherited dysfibrinogenemia pedigree associated with a heterozygous mutation in the FGA gene, and to investigate the pathogenesis of this disease. CLINICAL PRESENTATION: The proband of interest is a 29-year-old woman. She was in her 37 weeks of g...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.1055/a-1261-3884

    authors: Li S,Wang M,Li X,Xu Q,Liu S,Luo S,Chen Y

    更新日期:2020-12-01 00:00:00

  • RhoGAPs and Rho GTPases in platelets.

    abstract::Platelet cytoskeletal reorganization is essential for platelet adhesion and thrombus formation in hemostasis and thrombosis. The Rho GTPases RhoA, Rac1 and Cdc42 are the main players in cytoskeletal dynamics of platelets responsible for the formation of filopodia and lamellipodia to strongly increase the platelet surf...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-14-09-0046

    authors: Elvers M

    更新日期:2016-08-03 00:00:00

  • Birth Control Pills and Thrombotic Risks: Differences of Contraception Methods with and without Estrogen.

    abstract::In Germany one-third of the women in fertile age use combined oral contraceptives (COCs), which consist mostly of ethinylestradiol (EE) and a synthetic progestin. Older COCs with norethisterone or levonorgestrel have a lower risk for venous thromboembolism (VTE) than newer COCs with desogestrel, drospirenone, or gesto...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1055/s-0039-1677806

    authors: Rott H

    更新日期:2019-02-01 00:00:00

  • Acquired Haemophilia A Associated with Subsequent Hepatocellular Carcinoma.

    abstract::Acquired haemophilia A (AHA) is a rare autoimmune disease caused by antibodies directed against clotting factor VIII. About half of cases are idiopathic, but AHA may also be secondary to autoimmune, dermatologic, or oncologic diseases. In approximately 10% of non-idiopathic cases, the disease occurs after or with the ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.1055/s-0038-1668570

    authors: Pacholczak R,Bazan-Socha S,Zdziarska J,Iwaniec T,Walocha JA,Musiał J,Dropiński J

    更新日期:2019-02-01 00:00:00

  • Do we need antiplatelet therapy in thrombocytosis? Pro. Diagnostic and pathophysiologic considerations for a treatment choice.

    abstract::Thrombocytosis (defined as platelets >450 x 109/l) has several aetiologies. After having excluded spurious thrombocytosis (e. g., due to microspherocytes, schistocytes, cryoglobulins, or bacteria), the differential diagnosis of true thrombocytosis encompasses secondary causes (as diverse as inflammation, infection, ma...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-14-11-0074

    authors: Alberio L

    更新日期:2016-11-07 00:00:00

  • Feasibility and Results of a Mobile Haemophilia Outpatient Care Pilot Project.

    abstract:INTRODUCTION: Regular visits at haemophilia treatment centres (HTCs) in rural regions are often dependent on the access to a private car due to lack of or limited availability of public means. Therefore, a mobile haemophilia outpatient care (MHOC) concept providing home visits to haemophilia patients has been developed...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.1055/s-0038-1654721

    authors: Eichler H,Schleicher C,Heine S,Graf N,von Mackensen S

    更新日期:2018-08-01 00:00:00

  • [Inhibitor development after changing FVIII/IX products in patients with haemophilia].

    abstract:UNLABELLED:The retrospective observational study surveys the relationship between development of inhibitors in the treatment of haemophilia patients and risk factors such as changing FVIII products. A total of 119 patients were included in this study, 198 changes of FVIII products were evaluated. RESULTS:During the ob...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Kocher S,Asmelash G,Makki V,Müller S,Krekeler S,Alesci S,Miesbach W

    更新日期:2012-01-01 00:00:00

  • Old and new anticoagulants.

    abstract::Vitamin-K-antagonists (VKA) and heparins have been complementary anticoagulants for prevention and treatment of thrombosis for almost 70 years. In contrast to heparins, VKA have not been modified pharmacologically, however treatment surveillance has improved by introducing INR and self-monitoring/management. Disclosur...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/ha-1149

    authors: Harbrecht U

    更新日期:2011-02-01 00:00:00

  • DOAC use in patients with chronic kidney disease.

    abstract::Direct oral anticoagulants (DOACs) are increasingly prescribed substances in patients with indication for effective anticoagulation. Patients with chronic kidney disease (CKD) have a high burden of cardiovascular risk and are more likely to develop atrial fibrillation (AF) than patients without CKD. Patients with mild...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-17-01-0003

    authors: Kcükköylü S,Rump LC

    更新日期:2017-01-01 00:00:00

  • Child Abuse or Bleeding Disorder-An Interdisciplinary Approach.

    abstract::Children with an unexplained bleeding tendency are frequently referred to a haemostaseologist for further evaluation. Careful standardized history taking and clinical evaluation should allow for distinguishing bleeds after minor injury and trauma which are very common in all children. However, in two groups of childre...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1055/s-0039-1677714

    authors: Knöfler R,Streif W,Watzer-Herberth I,Hahn G,Schmidt U

    更新日期:2019-02-01 00:00:00